Open AccessRecombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures
Author(s) -
Igor Končar,
Nataša Savić
Publication year - 2008
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh0808367k
Subject(s) - medicine , surgery , inferior vena cava , abdominal aorta , aorta , abdominal aortic aneurysm , anesthesia , aneurysm
A recombinant form of activated factor VII (rFVIIa) is a haemostatic drug that is approved for use in haemophiliacs with antibodies to factor VIII or factor IX. Most recent studies and clinical experience have shown that rFVIIa (NovoSeven, Novo Nordisk A/S, Denmark) gives extreme haemostatic effect in patients with severe "non-haemophilic" bleeding produced after trauma and major surgery.